Skip to content

Role of Lactase in Infantile Colic

Efficacy and Safety of Lactase in Infantile Colic: A Randomized Placebo Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010930
Enrollment
160
Registered
2017-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified Health Condition 2: null- Infantile colic

Interventions

Intervention1: oral lactase drops: five drops of lactase with 50 ml of infant formula four times in a day for 28 days Control Intervention1: oral placebo: 5 drops of placebo added to 50 ml infant form

Sponsors

Walter Bushnell Laboratories Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Apparently clinically healthy infant who is <5 months of age with infantile colic with no evidence of failure to thrive, fever or illness

Exclusion criteria

Exclusion criteria: Infants born

Design outcomes

Primary

MeasureTime frame
Duration of crying in minutes/day; Number of days with colic (that lasts 3 hours/day). Timepoint: Duration of crying in minutes/day; Number of days with colic (that lasts 3 hours/day).

Secondary

MeasureTime frame
Parental satisfaction (on a Likert scale); Occurrence of adverse effects (e.g. milk regurgitation, vomiting, diarrhea, constipation, drowsiness). Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDR Manish Narang

University College of Medical Sciences & GTB Hospital

shahdheeraj@hotmail.com9868399792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 14, 2026